TERT and ependymoma: Our finding not only supports and extends a preliminary study by Ian et al., which reported unreliable detection of ctDNA in the CSF of their ependymoma cohort26, but also agreed with previous reports about the feasibility of TERT promoter alteration detection in glioblastoma patients27,28.